December 2017 Vol 10, No 9

December 2017 Vol 10, No 9

“Alexa, Refill My Omeprazole”

David B. Nash, MD, MBA

December 2017 Vol 10, No 9 - Editorial

Prospective Bundled Payments in a Changing Environment: The Experience of a Self-Funded, State-Sponsored Plan

Frank H. Lawler, MD, MSPH, Frank R. Wilson, CPA, G. Keith Smith, MD, Lynn V. Mitchell, MD, MPH

December 2017 Vol 10, No 9 - Original Research

Stakeholder Perspective

Oklahoma Benefits Program Setting an Example: A Cost-Effective Bundled Payments Option for State Employees

by James T. Kenney, RPh, MBA

The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use

Yuexin Tang, PhD, Xingyue Huang, PhD, Jinan Liu, PhD, R. Ravi Shankar, MD, Michael L. Ganz, PhD, Swapnil Rajpathak, MD, DrPH

December 2017 Vol 10, No 9 - Business, Original Research

Stakeholder Perspective

Impact of Step Therapy Restrictions in Diabetes Care

by Quang T. Nguyen, DO, FACP, FACE, FTOS

AMCP Nexus 2017 Highlights

December 2017 Vol 10, No 9 - Conference Highlights AMCP

Comparing the Medicaid Retrospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies

Sergio I. Prada, MPA, PhD

December 2017 Vol 10, No 9 - Regulatory

Stakeholder Perspective

Is the Federal Drug Utilization Review Requirement Just Red Tape or an Enlightened State of Flexibility?

by Michael Kleinrock

Results 1 - 5 of 5